Takeda makes Shire takeover proposal at about 46.50 pounds per share - sources

Image
Reuters LONDON
Last Updated : Apr 19 2018 | 4:50 PM IST

By Greg Roumeliotis and Ben Martin

LONDON (Reuters) - Takeda Pharmaceutical has made an indicative takeover proposal to British drugmaker Shire worth about 46.50 pounds a share, according to two sources with direct knowledge of the matter.

That would value London-listed Shire at about 43 billion pounds ($61 billion), according to Reuters data.

The move comes ahead of a deadline for the Japanese group to make a firm offer or walk away from the FTSE 100 company by April 25. Shares in Shire were up 5.3 percent at 39.59 pounds at 1032 GMT.

Takeda confirmed last month it was considering an offer for Shire, a rare disease specialist.

A spokesman for Takeda declined to comment and Shire did not return a request for comment.

($1 = 0.7039 pounds)

(Reporting by Greg Roumeliotis and Ben Martin; Editing by Jason Neely and Mark Potter)

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 19 2018 | 4:37 PM IST

Next Story